Substance tackles skin cancer from two sides

November 2, 2008

By playing it safe and using a two-pronged attack, a novel designer molecule fights malignant melanoma. It was created and tested by an international team of researchers led by the University of Bonn. On the one hand, the substance is similar to components of viruses and in this way alerts the immune system. The body's own defences are also strengthened against cancer cells in this process. At the same time, the novel molecule also puts pressure on the tumour in a different way. It switches off a specific gene in the malignant cells, thus driving them to suicide. With mice suffering from cancer, the researchers have thus been able to fight metastases in the lung. In Nature Medicine's November issue they report about this promising strategy.

For their research project, the scientists drew on the latest insights into biology's box of tricks. A close relative of the nuclear DNA, known as RNA, served them as therapy. It has only been known for a few years that small RNA molecules can basically be used to target certain genes and switch them off. This effect is called RNA interference; the Americans Craig Mellow and Andrew Fire were awarded the Nobel Prize in 2006 for its discovery.

'We used this method in order to drive the tumour cells to suicide,' the Bonn dermatology researcher Professor Thomas Tüting explains. Every single body cell is equipped with a corresponding suicide programme. It is activated, for example, if the cell becomes malignant. It dies before it can do any more harm. 'But in tumours a gene is active that suppresses this suicide programme,' Professor Tüting, who is head of the Experimental Dermatology Laboratory, explains. 'We have pinpointed this gene and switched it off by using RNA interference.'

At the same time the researchers also crept up on cancer by another route: 'We basically "disguised" our RNA,' Professor Gunther Hartmann, director of the Institute of Clinical Chemistry and Pharmacology says. 'That is why the immune system took it for the genetic makeup of a virus.' Many viruses actually do use RNA to store information. So if the body discovers RNA fragments which it takes to be the genetic makeup of a virus, it mounts an attack on them. By means of this trick the body's defences were prompted to tackle the tumour cells far more aggressively than normal.

RNA is also present in the body's own cells. For a long time it was not known how the immune system distinguishes between 'harmful' and 'harmless' RNA. Only two years ago, Professor Hartmann was able to shed light on the problem in a sensational article in the journal 'Science'. The scientists used this knowledge in order to modify the RNA substance in such a way that it was able to alert the immune system.

'The beauty of this method is that we can attack the cancer with one designer molecule along two completely different routes,' Professor Hartmann says. 'This way the tumour is deprived of opportunities of sidestepping the attack that make successful therapy so difficult in other cases.' Initial experiments in mouse models have shown that growth of metastases in the lungs is inhibited significantly by the new molecule. The therapy even led to the secondary tumours becoming smaller or even disappearing entirely.

Despite this, the research team warns against excessive optimism: 'What works in mice does not necessarily prove successful in humans as well,' Professor Tüting warns. 'Apart from that, many issues need to be addressed before a trial with cancer patients can even be thought of.' Still, the approach appears very promising, especially as the therapeutic RNA molecule can be easily customised to suit different kinds of cancer.

This article is available online from November 2nd (doi: 10.1038/nm.1887).

Source: University of Bonn


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 4.6 /5 (16 votes)

Rank Filter

Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

  • E_L_Earnhardt - Nov 03, 2008
    • Rank: 1 / 5 (1)
    Amazing work! Still, I am more interested in CORRECTING the malfunctions of the cell than KILLING it. SLOWING mitosis to a normal rate seems more natural than KILLING IT! Modifying cyroablation to accomplish this seems better!

November 2, 2008 all stories

Comments: 1

4.6 /5 (16 votes)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories

  • Researchers discover biological basis of 'bacterial immune system'
    created 13 hours ago | popularity not rated yet | comments 0
  • 'Cross-talk' mechanism contributes to colorectal cancer
    created Nov 13, 2009 | popularity not rated yet | comments 0
  • Explained: RNA interference
    created Nov 12, 2009 | popularity not rated yet | comments 0
  • Experimental agent reduces breast cancer metastasis to bone
    created Nov 03, 2009 | popularity not rated yet | comments 0
  • New activity found for a potential anti-cancer agent
    created Nov 02, 2009 | popularity not rated yet | comments 0



  • hide
  • Relevant PhysicsForums posts

  • 23 Years in a Vegetative State....or not?
    created Nov 25, 2009
  • Has the H1N1 vaccine been scientifically proven to work?
    created Nov 24, 2009
  • nesfatin
    created Nov 22, 2009
  • Obsessive Compulsive Disorder
    created Nov 20, 2009
  • More from Physics Forums - Medical Sciences

Other News

Implant-based cancer vaccine is first to eliminate tumors in mice

Implant-based cancer vaccine is first to eliminate tumors in mice

Medicine & Health / Cancer

created 11 hours ago | popularity 4.9 / 5 (16) | comments 3

(PhysOrg.com) -- A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal ...


Brain's endocannabinoid signaling pathway kept in check by two enzymes

Medicine & Health / Research

created 8 hours ago | popularity 5 / 5 (2) | comments 0

(PhysOrg.com) -- A research team has shown that blocking the degradation of two naturally occurring cannabinoids in the endocannabinoid signaling pathway of the brain produces marijuana-like behavioral effects in mice, according ...


Scale of justice

fMRI scans used in murder trial sentencing

Medicine & Health / Other

created 19 hours ago | popularity 1 / 5 (1) | comments 4

(PhysOrg.com) -- Functional Magnetic Resonance Imaging (fMRI) scans have been used, possibly for the first time, in the sentencing phase of a murder trial in Chicago in the US.


Long-term testicular cancer survivors at high risk for neurological side effects

Medicine & Health / Cancer

created 4 hours ago | popularity not rated yet | comments 0

Long-term survivors of testicular cancer who were treated with cisplatin-based chemotherapy had more severe side effects, including neurological side effects and Raynaud-like phenomena, than men who were not treated with ...


Scientists find emotion-like behaviors, regulated by dopamine, in fruit flies

Medicine & Health / Neuroscience

created 12 hours ago | popularity 5 / 5 (3) | comments 0

Scientists at the California Institute of Technology have uncovered evidence of a primitive emotion-like behavior in the fruit fly, Drosophila melanogaster. Their findings, which may be relevant to the relationship betwee ...